Latest Investments News

CAR Group Limited has reported strong FY25 financial results with double-digit revenue and earnings growth across all key markets, while preparing for a leadership change. The company’s optimistic FY26 outlook underscores confidence in sustained expansion driven by innovation and market leadership.

CAR Group Limited reported a strong FY25 with revenue up 8% to $1.18 billion and net profit after tax rising 12% to $293 million, while announcing a leadership transition as CEO Cameron McIntyre steps down.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

MAC Copper has secured a crucial regulatory green light from the South African Reserve Bank, advancing Harmony Gold’s proposed acquisition. Shareholders are now gearing up to vote on the deal at meetings scheduled for late August.

Ariadne Australia Limited anticipates a near breakeven total comprehensive income for FY25, balancing solid profits with significant portfolio losses and partnership costs.

Platinum Capital Limited has formally cancelled its planned scheme meeting following the withdrawal of a proposed restructure, yet the scheduled general meeting will proceed as planned on 12 August 2025.

The Federal Court of Australia has approved Ideagen’s acquisition of Envirosuite via a scheme of arrangement, setting the stage for a $0.09 per share cash payout to shareholders.

The Calmer Co. has secured a long-term lease for its Navua facility in Fiji, replacing a planned property purchase and freeing up capital to accelerate its US market expansion.

American West Metals has launched an offer of over 104 million new options to select investors and advisors, potentially raising $6.28 million upon exercise. The move aims to enhance liquidity and support ongoing exploration projects.

Avita Medical reported an 18% revenue increase and a 30% reduction in net loss for the first half of 2025, signaling progress as it scales commercial operations and targets profitability by 2026.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.